Would You Rather: Short Johnson & Johnson or Buy Dendreon?

Investing is often filled with tough choices and opportunity costs. This game segment from The Motley Fool's Where The Money Is poses a hypothetical question:

Would you rather short Johnson & Johnson (JNJ -1.15%) or buy Dendreon (NASDAQ: DNDN)?

Healthcare analysts David Williamson and Michael Douglass continue their game of "would you rather" by discussing a blue chip stalwart and a biotech struggling with lackluster sales. Watch and find out which strategy David chooses and his arguments for it.